Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
08/19PATENT ISSUED FOR NEEDLE SAFETY ASSEMBLY (USPTO 10,368,790) : Poly Medicure Limited
AQ
08/19ZOSANO PHARMA CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
08/19PATENT ISSUED FOR NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES (USPTO 10,369,164) : Abbott Laboratories
AQ
08/19DATA FROM BRISTOL-MYERS SQUIBB COMPANY PROVIDE NEW INSIGHTS INTO HEPATITIS C VIRUS (EVOLUTION OF THE BURDEN OF ACTIVE HEPATITIS C VIRUS INFECTION IN ENGLAND FROM SEPTEMBER 2015 TO SEPTEMBER 2016 : a repeated cross-sectional analysis): Liver Diseases and Conditions - Hepatitis C Virus
AQ
08/19BELLICUM PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/19CANCER GENETICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
08/19PATENT APPLICATION TITLED “METHOD OF PRODUCING PROTON PUMP INHIBITOR COMPOUND HAVING OPTICAL ACTIVITY” PUBLISHED ONLINE (USPTO 20190232266) : Towa Pharmaceutical Co. Ltd.
AQ
08/19RESEARCHERS SUBMIT PATENT APPLICATION, “SAMPLE RECEIVING SYSTEM AND METHODS”, FOR APPROVAL (USPTO 20190232294) : Laboratory Corporation of America Holdings
AQ
08/19PREDICTIVE ONCOLOGY : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
08/19PATENT ISSUED FOR EXPANDABLE INTERVERTEBRALSPACER (USPTO 10,369,004) : Globus Medical Inc.
AQ
08/19MARKER THERAPEUTICS : Initial statement of beneficial ownership of securities
PU
08/19PLX PHARMA INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
08/19AMERICANN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
08/19PREDICTIVE ONCOLOGY INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
08/19A STUDY TO EVALUATE THE PHARMACOKINETICS AND GLUCODYNAMICS OF LY900014 FOLLOWING SINGLE DOSE ADMINISTRATION IN HEALTHY CHINESE SUBJECTS : Drugs and Therapies - Antidiabetic Agents
AQ
Discover
03:01aKarolinska Development's portfolio company Forendo Pharma commences Phase 1b study of its drug candidate FOR-6219
GL
03:00aDR REDDY LABORATORIES : Announces the Launch of Vigabatrin Powder for Oral Solution, USP in the U.S. Market
BU
02:47aLIDCO : Capital Markets Day
PU
02:47aLIDCO : Trading update & Notice of results
PU
02:37aERGOMED : Board Appointment
PU
02:14aAMGEN : Prosecution History Estoppel Leads To Dismissal Of DOE Claim
AQ
02:02aCOLOPLAST : Announcement no. 8/2019 - Meet the Management Event 2019
AQ
02:01aONCOPEPTIDES : appoints Klaas Bakker as new Chief Medical Officer
AQ
02:01aNORDIC NANOVECTOR : appoints Dr Lars Nieba as Chief Technology Officer
AQ
02:01aOREXO : signs partnership agreement with GAIA to develop and commercialize a new digital therapy for the treatment of Opioid Use Disorder
AQ
02:01aIMMUNICUM : publ) Interim Report January – June 2019
AQ
02:01aASTRAZENECA : Farxiga met primary endpoint in landmark Phase III
AQ
02:01aNomination committee in Oasmia for the 2019 AGM
GL
01:51aPHARMACIELO : Completes First CBD Shipment to Switzerland
AQ
01:51aMEDMEN ENTERPRISES : Jumps on Introduction of California Delivery Service
AQ
01:51aCANNTRUST : Ontario Returns “Non-conforming” CannTrust Items Worth C$2.9 Million
AQ
01:46aASCELIA PHARMA : Invitation to presentation of Ascelia Pharma's Q4 report 2018/2019
AQ
01:42aMITHRA PHARMACEUTICALS : Signs LSA for Commercialization of Estelle® and Myring™ in Israel
PU
01:36aMOLINA HEALTHCARE : volunteers hold 'Christmas in July' party for Steps 4 Life clients
AQ
01:22aAMBEA PUBL : interim report April-June 2019
PU
01:15aBasilea reports significantly increased cash-generating revenue, flat operating expenses and reduced net loss for half-year 2019
GL
01:10aMEDARTIS : announces half-year 2019 results
EQ
01:01aAMBEA PUBL : interim report April-June 2019
AQ
12:51aMANZO PHARMACEUTICALS : Pharmaceutical company Manzo Pharmaceuticals earns great reviews for patented long-lasting lactose digestion aid
AQ
12:02aKHIRON LIFE SCIENCES : Announces DTC Eligibility, Increasing Access for U.S. Investors
AQ
08/19ORASURE TECHNOLOGIES : sells cryosurgical systems business for $12 million to its neighbor in Bethlehem
AQ
08/19MYRIAD GENETICS : Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations, Investors With Losses Should Contact Firm
PR
08/19GLANCY PRONGAY & MURRAY LLP : Files a Securities Class Action on Behalf of Nektar Therapeutics Investors (NKTR)
BU
08/19LIBERTY HEALTH SCIENCES : Sells Alachua, FL Property Along With Ohio Based Assets
AQ
08/19SONIC HEALTHCARE : CEO Presentation Full Year Results to 30 June 2019 Opens in a new Window
PU
08/19SONIC HEALTHCARE : Media Release Full Year Results to 30 June 2019 Opens in a new Window
PU
08/19CLINUVEL PHARMACEUTICALS : Newsletter
PU
08/19SONIC HEALTHCARE : Dividend/Distribution - SHL Opens in a new Window
PU
08/19SONIC HEALTHCARE : Preliminary Final Report Opens in a new Window
PU
08/19EVE : Announces Financial Results for the Three and Six Month Periods Ended June 30, 2019
AQ
08/19PATTERSON : First-Quarter Fiscal 2020 Conference Call Scheduled for Thursday, August 29, 2019
BU
08/19INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
BU
08/19Dynasil Corporation of America's Announces Filing of Form 25 and Suspension of Trading of Common Stock on Nasdaq
GL
08/19GILEAD SCIENCES STATEMENT ON U.S. FOOD AND DRUG ADMINISTRATION ADVISORY COMMITTEE'S RECOMMENDATION ON DESCOVY FOR PREP™ : Gilead Sciences Inc.
AQ
08/19PATENT ISSUED FOR DISPLAYING COMPUTER-AIDED DETECTION INFORMATION WITH ASSOCIATED BREAST TOMOSYNTHESIS IMAGE INFORMATION (USPTO 10,368,817) : Hologic Inc.
AQ
08/19AN APPLICATION FOR THE TRADEMARK “XKARTES” HAS BEEN FILED BY GILEAD SCIENCES : Gilead Sciences
AQ
08/19DECIPHERA PHARMACEUTICALS, INC. ANNOUNCES SECOND QUARTER 2019 FINANCIAL RESULTS : Deciphera Pharmaceuticals Inc.
AQ
08/19FINDINGS FROM BEIJING ADVANCED INNOVATION CENTER FOR FOOD NUTRITION AND HUMAN HEALTH IN THE AREA OF FOOD SCIENCE DESCRIBED : Science - Food Science
AQ
08/19UNITEDHEALTH GROUP SUPPORTING PEOPLE AFFECTED BY MASS SHOOTING IN DAYTON : UnitedHealth Group
AQ
08/19JAPAN - PATENT ISSUED FOR SURGICAL TREATMENT APPARATUS (USPTO 10,368,935) : Olympus Corporation
AQ
08/19Sarepta Therapeutics Receives Complete Response Letter from the US Food and Drug Administration for Golodirsen New Drug Application
GL
08/19BOSTON SCIENTIFIC : Sci closes on $4.3 billion deal for British health company BTG
AQ
08/19BOSTON SCIENTIFIC : Announces FDA Approval Of ImageReady™ MRI For Vercise Gevia™ Deep Brain Stimulation System
PR
08/19PDL BIOPHARMA, INC. (NASDAQ : PDLI) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
AQ
08/19“COMPRESSOR/DISTRACTOR” IN PATENT APPLICATION APPROVAL PROCESS (USPTO 20190231394) : Globus Medical Inc.
AQ
03:09aVANDA PHARMACEUTICALS : Company 'perplexed' as to why drug that claims to cure jet lag held up by FDA
AQ
03:07aASTRAZENECA : Farxiga met primary endpoint in landmark Phase III DAPA-HF trial for the treatment of patients with heart failure
PU
03:06aAGRAFLORA ORGANICS INTERNATIONAL : Enters Into Exclusive Asian CBD Cosmetics Distribution Agreement; Achieves Immediate Access to China's Projected US$15,000,000,000 CBD Marketplace
AQ
03:02aRICHTER GEDEON VEGYESZETI GYAR : launched Terrosa®, its biosimilar teriparatide across Europe
PU
03:01aNexstim reports good initial results on the use of Smartfocus® technology in treatment of major depressive disorder
GL
Prev.1  2   3  4  5  6  7  8  9  10Next
Advertisement